Literature DB >> 18758239

FoxM1 is degraded at mitotic exit in a Cdh1-dependent manner.

Jamila Laoukili1, Monica Alvarez-Fernandez, Marie Stahl, René H Medema.   

Abstract

The Forkhead transcription factor FoxM1 is required for the timely expression of many mitotic regulators, such as Cyclin B, Plk1, Aurora B and Cdc25B.(1-3) For this, FoxM1 is specifically activated in G(2) phase through Cyclin A/cdk2-dependent phosphorylation.(4-6) However, it is currently unclear how FoxM1 activity is removed as cells complete mitosis, and need to shut down expression of the mitotic regulators that are transcriptional targets of FoxM1. Here, we demonstrate that FoxM1 is actively degraded during exit from mitosis by the APC/C. We find that FoxM1 degradation requires Cdh1, a known co-factor for APC/C that is responsible for degradation of many mitotic regulators from anaphase until early G(1). FoxM1 binds to Cdh1, and FoxM1 degradation involves both D- and KEN-boxes present in the N-terminal part of FoxM1. Based on these data we propose that Cdh1-dependent degradation of FoxM1 is required to shut down transcriptional activation of mitotic regulators during exit from mitosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18758239     DOI: 10.4161/cc.7.17.6580

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  54 in total

1.  Recovery from a DNA-damage-induced G2 arrest requires Cdk-dependent activation of FoxM1.

Authors:  Mónica Alvarez-Fernández; Vincentius A Halim; Lenno Krenning; Melinda Aprelia; Shabaz Mohammed; Albert J Heck; René H Medema
Journal:  EMBO Rep       Date:  2010-04-09       Impact factor: 8.807

2.  Critical role of O-Linked β-N-acetylglucosamine transferase in prostate cancer invasion, angiogenesis, and metastasis.

Authors:  Thomas P Lynch; Christina M Ferrer; S RaElle Jackson; Kristina S Shahriari; Keith Vosseller; Mauricio J Reginato
Journal:  J Biol Chem       Date:  2012-01-24       Impact factor: 5.157

3.  High Fat Diet Regulation of β-Cell Proliferation and β-Cell Mass.

Authors:  M L Golson; A Ackermann Misfeldt; U G Kopsombut; C P Petersen; M Gannon
Journal:  Open Endocrinol J       Date:  2010

4.  Protein phosphatase 2A (B55α) prevents premature activation of forkhead transcription factor FoxM1 by antagonizing cyclin A/cyclin-dependent kinase-mediated phosphorylation.

Authors:  Mónica Alvarez-Fernández; Vincentius A Halim; Melinda Aprelia; Jamila Laoukili; Shabaz Mohammed; René H Medema
Journal:  J Biol Chem       Date:  2011-08-03       Impact factor: 5.157

5.  Metadherin/Astrocyte elevated gene-1 positively regulates the stability and function of forkhead box M1 during tumorigenesis.

Authors:  Lixuan Yang; Kejun He; Sheng Yan; Yibing Yang; Xinya Gao; Maolei Zhang; Zhibo Xia; Zhengsong Huang; Suyun Huang; Nu Zhang
Journal:  Neuro Oncol       Date:  2017-03-01       Impact factor: 12.300

6.  Wnt-induced deubiquitination FoxM1 ensures nucleus β-catenin transactivation.

Authors:  Yaohui Chen; Yu Li; Jianfei Xue; Aihua Gong; Guanzhen Yu; Aidong Zhou; Kangyu Lin; Sicong Zhang; Nu Zhang; Cara J Gottardi; Suyun Huang
Journal:  EMBO J       Date:  2016-02-24       Impact factor: 11.598

7.  FBXO31 protects against genomic instability by capping FOXM1 levels at the G2/M transition.

Authors:  J M Jeffery; M Kalimutho; P Johansson; D G Cardenas; R Kumar; K K Khanna
Journal:  Oncogene       Date:  2016-08-29       Impact factor: 9.867

8.  Farnesoid X receptor alleviates age-related proliferation defects in regenerating mouse livers by activating forkhead box m1b transcription.

Authors:  Wei-Dong Chen; Yan-Dong Wang; Lisheng Zhang; Steven Shiah; Meihua Wang; Fan Yang; Donna Yu; Barry M Forman; Wendong Huang
Journal:  Hepatology       Date:  2010-03       Impact factor: 17.425

9.  Cyclin A/Cdk2 regulates Cdh1 and claspin during late S/G2 phase of the cell cycle.

Authors:  Vanessa Oakes; Weili Wang; Brittney Harrington; Won Jae Lee; Heather Beamish; Kee Ming Chia; Alex Pinder; Hidemasa Goto; Masaki Inagaki; Sandra Pavey; Brian Gabrielli
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

10.  FOXM1 is a transcriptional target of ERalpha and has a critical role in breast cancer endocrine sensitivity and resistance.

Authors:  J Millour; D Constantinidou; A V Stavropoulou; M S C Wilson; S S Myatt; J M-M Kwok; K Sivanandan; R C Coombes; R H Medema; J Hartman; A E Lykkesfeldt; E W-F Lam
Journal:  Oncogene       Date:  2010-03-08       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.